Status:
COMPLETED
First Trimester Screening for Preeclampsia and Intrauterine Growth RestrIction Using Three Dimensional Doppler Angiography
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Pre-Eclampsia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Introduction: Preeclampsia (PE) and intrauterine growth restriction (IUGR) are two major pregnancy complications, related to a chronic utero-placental hypoperfusion. Nowadays, there isn't a screening ...
Eligibility Criteria
Inclusion
- Singleton nulliparous pregnant women between 11 and 13+6 gestation weeks.
- Mandatory enrolment in a social security plan,
- Patient (or a third person, independent from the investigator and the sponsor, in case of inability to read or write) having signed an informed consent.
Exclusion
- Patients under a measure of legal protection.
- Patient under 18,
- Absence of social insurance,
- Patient participating simultaneously to other interventional research trial to test a pharmaceutical treatment and protocols are not compatible,
- Inability to understand and accept the protocol.
Key Trial Info
Start Date :
April 16 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 14 2022
Estimated Enrollment :
2159 Patients enrolled
Trial Details
Trial ID
NCT03342014
Start Date
April 16 2018
End Date
November 14 2022
Last Update
December 12 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Régional Universitaire de Nancy
Vandœuvre-lès-Nancy, France, 54500